Our cutting edge biosensor technology provides you with advantages when developing new pharmaceuticals.
We offer you a contract research process enabled by our proven technology and a team of highly experienced application specialists. We select the best candidates to maximize your operations.
Our third generation biosensors technology is unique and patented and reduces animal testing and makes the drug development process more efficient and cost effective.
Attana will be present at Småbolagsdagen (represented by Swedish Shareholders' Association) June 3, 2019 at Sheraton in Stockholm between 08.00 and 18.00. Attana will give a company presentation and will be available to answer questions.
Attana will attend at Affinity, an conference organized by International Society of Molecular Recognition in Stockholm starting on Wednesday the 26th of June to Friday the 28th of June.